Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

1199::0088 yregruS 642 Benign prostatic hyperplasia Benign prostatic hyperplasia (BPH) is common (24% if aged 40–64; 40% if older). Pathology: Benign nodular or diff use proliferation of musculofi brous and glandular layers of the prostate. Inner (transitional) zone enlarges in contrast to peripheral lay- er expansion seen in prostate carcinoma. Features: Lower urinary tract symptoms (LUTS) = nocturia, frequency, urgency, post-micturition dribbling, poor stream/fl ow, hesitancy, overfl ow incontinence, haematuria, bladder stones, UTI. Management: Assess severity of symptoms and impact on life. PR exam. Tests: MSU; U&E; ultrasound (large residual volume, hydronephrosis—fi g 13.49), PSA (prior to PR exam; see also BOX ‘Advice to asymptomatic men’, p645), transrectal US ± biopsy. Then consider: • Lifestyle: Avoid caff eine, alcohol (to urgency/nocturia). Relax when voiding. Void twice in a row to aid emptying. Control urgency by pract ising distraction methods (eg breathing exercises). Train the bladder by ‘holding on’ to  time between voiding. • Drugs are useful in mild disease, and while awaiting surgery. • -blockers are 1st line (eg tamsulosin 400mcg/d PO; also alfuzosin, doxazosin, terazosin). Smooth muscle tone (prostate and bladder). SE: drowsiness; depression; dizziness; BP; dry mouth; ejaculatory failure; extra-pyramidal signs; nasal congestion; weight. • 5-reductase inhibitors:
